381 Millennium - A Marquis Who’s Who Magazine SCIENCES, PHARMACEUTICALS AND BIOTECHNOLOGY Kendra Grichuhin first joined Supernus Pharmaceuticals, Inc., in 2016, where she worked as an assistant director of regulatory affairs for five years. Since departing from that role, she has excelled as the director of regulatory affairs. During her tenure at the pharmaceutical company, Ms. Grichuhin was the regulatory lead for the program for the epilepsy medication Oxtellar XR, as well as the regulatory representative for one of the company’s investigational programs. Likewise, she served as the regulatory and program lead in relation to the development of a medication that treats depression and a nonstimulant medication that treats attention deficit hyperactivity disorder (ADHD). Earlier in her career, Ms. Grichuhin served Vanda Pharmaceuticals for two years, where she worked with genotyping samples. She subsequently joined their regulatory affairs department in 2008 and, in 2015, was promoted to a regulatory and quality assurance manager. She draws upon an Associate of Science from the Community College of Baltimore County, a Bachelor of Science from Towson University and a Master of Science in microbiology from the University of Iowa. Ms. Grichuhin specializes in communications, submissions and strategies in compliance with the Food and Drug Administration. She is also a member of the Regulatory Affairs Professionals Society. In accounting for her success, she credits the mentorship she has received over the course of her longstanding career, which has allowed her to rise to the lauded role she is recognized in today. Ms. Grichuhin notes that she developed a strong interest in the pharmaceutical industry in light of its innovative and flowing development of new therapeutic models and techniques. In the forthcoming years, Ms. Grichuhin intends to witness the continued growth of her career and aspires to be promoted to a higher executive position. Additionally, she would like to maintain her active involvement in gaining approvals for marketable drugs to help more patients across the United States and globally. Millennium Magazine Featured Listee KENDRA GRICHUHIN DIRECTOR OF REGULATORY AFFAIRS Supernus Pharmaceuticals, Inc. Westminster, MD
RkJQdWJsaXNoZXIy MTQ5NDA2